| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Cullen Eye Institute, Departments of Ophthalmology and Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
PURPOSE. In addition to acting as an optical filter, macular (carotenoid) pigment has been hypothesized to function as an antioxidant in the human retina by inhibiting the peroxidation of long-chain polyunsaturated fatty acids. However, at its location of highest density in the inner (prereceptoral) layers of the foveal retina, a specific requirement for antioxidant protection would not be predicted. The purpose of this study was to determine whether lutein and zeaxanthin, the major carotenoids comprising the macular pigment, are present in rod outer segment (ROS) membranes where the concentration of long-chain polyunsaturated fatty acids, and susceptibility to oxidation, is highest.
METHODS. Retinas from human donor eyes were dissected to obtain two regions: an annular ring of 1.5- to 4-mm eccentricity representing the area centralis excluding the fovea (perifoveal retina) and the remaining retina outside this region (peripheral retina). ROS and residual (ROS-depleted) retinal membranes were isolated from these regions by differential centrifugation and their purity checked by polyacrylamide gel electrophoresis and fatty acid analysis. Lutein and zeaxanthin were analyzed by high-performance liquid chromatography and their concentrations expressed relative to membrane protein. Preparation of membranes and analysis of carotenoids were performed in parallel on bovine retinas for comparison to a nonprimate species. Carotenoid concentrations were also determined for retinal pigment epithelium harvested from human eyes.
RESULTS. ROS membranes prepared from perifoveal and peripheral regions of human retina were found to be of high purity as indicated by the presence of a dense opsin band on protein gels. Fatty acid analysis of human ROS membranes showed a characteristic enrichment of docosahexaenoic acid relative to residual membranes. Membranes prepared from bovine retinas had protein profiles and fatty acid composition similar to those from human retinas. Carotenoid analysis showed that lutein and zeaxanthin were present in ROS and residual human retinal membranes. The combined concentration of lutein plus zeaxanthin was 70% higher in human ROS than in residual membranes. Lutein plus zeaxanthin in human ROS membranes was 2.7 times more concentrated in the perifoveal than the peripheral retinal region. Lutein and zeaxanthin were consistently detected in human retinal pigment epithelium at relatively low concentrations.
CONCLUSIONS. The presence of lutein and zeaxanthin in human ROS membranes raises the possibility that they function as antioxidants in this cell compartment. The finding of a higher concentration of these carotenoids in ROS of the perifoveal retina lends support to their proposed protective role in age-related macular degeneration.
This article has been cited by other articles:
|
|
 |
|
  E Loane, C Kelliher, S Beatty, and J M Nolan The rationale and evidence base for a protective role of macular pigment in age-related maculopathy Br. J. Ophthalmol., September 1, 2008; 92(9): 1163 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Chucair, N. P. Rotstein, J. P. SanGiovanni, A. During, E. Y. Chew, and L. E. Politi Lutein and Zeaxanthin Protect Photoreceptors from Apoptosis Induced by Oxidative Stress: Relation with Docosahexaenoic Acid Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5168 - 5177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. E. K. Wolf-Schnurrbusch, N. Roosli, E. Weyermann, M. R. Heldner, K. Hohne, and S. Wolf Ethnic Differences in Macular Pigment Density and Distribution Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3783 - 3787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bhosale, D. Y. Zhao, B. Serban, and P. S. Bernstein Identification of 3-Methoxyzeaxanthin as a Novel Age-Related Carotenoid Metabolite in the Human Macula Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1435 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Aleman, A. V. Cideciyan, E. A. M. Windsor, S. B. Schwartz, M. Swider, J. D. Chico, A. Sumaroka, A. Y. Pantelyat, K. G. Duncan, L. M. Gardner, et al. Macular Pigment and Lutein Supplementation in ABCA4-Associated Retinal Degenerations Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1319 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Grayson and R. S. Molday Dominant Negative Mechanism Underlies Autosomal Dominant Stargardt-like Macular Dystrophy Linked to Mutations in ELOVL4 J. Biol. Chem., September 16, 2005; 280(37): 32521 - 32530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Li, B. H. Chung, J. B. Presley, G. Malek, X. Zhang, N. Dashti, L. Li, J. Chen, K. Bradley, H. S. Kruth, et al. Lipoprotein-like Particles and Cholesteryl Esters in Human Bruch's Membrane: Initial Characterization Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2576 - 2586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Orjuela, L. Titievsky, X. Liu, M. Ramirez-Ortiz, V. Ponce-Castaneda, E. Lecona, E. Molina, K. Beaverson, D. H. Abramson, and N. E. Mueller Fruit and Vegetable Intake during Pregnancy and Risk for Development of Sporadic Retinoblastoma Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1433 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Johnson, M. Neuringer, R. M. Russell, W. Schalch, and D. M. Snodderly Nutritional Manipulation of Primate Retinas, III: Effects of Lutein or Zeaxanthin Supplementation on Adipose Tissue and Retina of Xanthophyll-Free Monkeys Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 692 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Ribaya-Mercado and J. B. Blumberg Lutein and Zeaxanthin and Their Potential Roles in Disease Prevention J. Am. Coll. Nutr., December 1, 2004; 23(suppl_6): 567S - 587S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bhosale, A. J. Larson, J. M. Frederick, K. Southwick, C. D. Thulin, and P. S. Bernstein Identification and Characterization of a Pi Isoform of Glutathione S-Transferase (GSTP1) as a Zeaxanthin-binding Protein in the Macula of the Human Eye J. Biol. Chem., November 19, 2004; 279(47): 49447 - 49454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Gale, N. F. Hall, D. I. W. Phillips, and C. N. Martyn Lutein and Zeaxanthin Status and Risk of Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2461 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Khachik, F. F. de Moura, D.-Y. Zhao, C.-P. Aebischer, and P. S. Bernstein Transformations of Selected Carotenoids in Plasma, Liver, and Ocular Tissues of Humans and in Nonprimate Animal Models Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3383 - 3392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Thomson, Y. Toyoda, A. Langner, F. C. Delori, K. M. Garnett, N. Craft, C. R. Nichols, K. M. Cheng, and C. K. Dorey Elevated Retinal Zeaxanthin and Prevention of Light-Induced Photoreceptor Cell Death in Quail Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3538 - 3549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Toyoda, L. R. Thomson, A. Langner, N. E. Craft, K. M. Garnett, C. R. Nichols, K. M. Cheng, and C. K. Dorey Effect of Dietary Zeaxanthin on Tissue Distribution of Zeaxanthin and Lutein in Quail Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1210 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. O. Edwards, L. A. Donoso, and R. Ritter III A Novel Gene for Autosomal Dominant Stargardt-like Macular Dystrophy with Homology to the SUR4 Protein Family Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2652 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Delori, D. G. Goger, and C. K. Dorey Age-Related Accumulation and Spatial Distribution of Lipofuscin in RPE of Normal Subjects Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1855 - 1866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Aleman, J. L. Duncan, M. L. Bieber, E. de Castro, D. A. Marks, L. M. Gardner, J. D. Steinberg, A. V. Cideciyan, M. G. Maguire, and S. G. Jacobson Macular Pigment and Lutein Supplementation in Retinitis Pigmentosa and Usher Syndrome Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1873 - 1881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Beatty, I. J. Murray, D. B. Henson, D. Carden, H.-H. Koh, and M. E. Boulton Macular Pigment and Risk for Age-Related Macular Degeneration in Subjects from a Northern European Population Invest. Ophthalmol. Vis. Sci., February 1, 2001; 42(2): 439 - 446. [Abstract] [Full Text]
|
|
|
|
|
|
R. A. Bone, J. T. Landrum, S. T. Mayne, C. M. Gomez, S. E. Tibor, and E. E. Twaroska Macular Pigment in Donor Eyes with and without AMD: A Case-Control Study Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 235 - 240. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
